Personalize allergy treatment with our wide range of extracts

Discover available allergy treatment options and products so you can tailor treatment based on your patients’ needs.

Available allergen immunotherapy (AIT) options

These methods have been shown to address the root cause of allergies, offering potential long-term relief by desensitizing the immune system and reducing its response.1,2

Subcutaneous
immunotherapy (SCIT)

Usually known as allergy shots, SCIT involves gradually increasing doses of allergens injected under the skin. It trains the immune system to tolerate allergens, reducing symptoms over time.1,2

Sublingual
immunotherapy (SLIT)

SLIT offers needle-free exposure by placing allergenic extracts in tablet form under the tongue for absorption. The allergen enters the bloodstream (and modulates the immune system).1,3

Oral immunotherapy (OIT)

involves consuming small, carefully increased amounts of an allergen under medical supervision. It is commonly used to treat food allergy.1

Have patients struggling with peanut allergy?
See an OIT option.

Explore a treatment option

Learn more about a sublingual grass allergy immunotherapy tablet.

Discover a treatment option

Our commitment to you—from cultivation to quality control

Our Biologics Department collects, sources, identifies, and cultivates raw allergenic materials such as pollens, offering over 150 pollen extracts.4

Our Quality Control Lab performs a minimum of 16 tests, including chemical and microbial assays, on each extract before release.4

Our Mycology Department grows more than 60 fungal cultures, maintaining stock cultures for safety and supply.4

Our SD/SEV Department produces up to half a million vials monthly, each inspected by trained personnel.4

Take an inside look at our process.


SD=sterile diluent; SEV=sterile empty vial.

Products for every allergy practice

  • GREER® Extracts™*
  • GREER® Sterile Diluents™
  • GREER® Sterile Empty Vials™
  • GREER® Versa Vial Rack®
  • Skintester OMNI™
  • GREER® Pick®

*Please see Important Safety Information for GREER® Extracts™ below.

Please click here for Package Inserts with full Prescribing Information, including Boxed Warnings.

Specialized service offerings

GREER®
Pharmacy

Order customized formulations, dosages, and strengths made specifically for each patient based on your prescription instructions.

Explore GREER® Pharmacy

Stallergenes Greer
Service Team

Three different specialty teams are available to help you at every stage of the ordering process.

Get help now

Skin Testing
Review Sessions

Sign up for live or virtual review sessions to learn proper technique for using Skintestor OMNI™ and GREER® Pick®.

Sign up for a review

INDICATIONS

Allergenic extracts are indicated for skin test diagnosis and treatment (immunotherapy) of patients with seasonal and perennial allergies.

IMPORTANT SAFETY INFORMATION

WARNING: SEVERE ALLERGIC REACTIONS

  • Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis.
  • Do not administer allergenic extracts to patients with severe, unstable, or uncontrollable asthma.
  • Observe patients in the office for at least 30 minutes following treatment. Emergency measures and personnel trained in their use must be available immediately in the event of a life-threatening reaction.
  • Immunotherapy may not be suitable for patients with certain underlying medical conditions that may reduce their ability to survive a systemic allergic reaction.
  • Allergenic extracts may not be suitable for patients receiving medications such as beta-blockers that may make them unresponsive to epinephrine or inhaled bronchodilators.

Do not inject intravenously. Initial dose should be based on skin test reactivity.

The most common adverse reactions include localized erythema, itching, swelling, tenderness, and pain. Systemic adverse reactions include generalized skin erythema, urticaria, pruritus, angioedema, rhinitis, wheezing, chest tightness, laryngeal edema, and hypotension.

INDICATIONS

Non-Standardized Allergenic Extracts: Allergenic extracts are indicated for skin test diagnosis of patients with a clinical history of allergies to one or more of the specific allergens and treatment for reduction of allergen-induced allergic symptoms confirmed by positive skin tests or in vitro testing for allergen-specific IgE antibodies. Food extracts have not been proven safe or effective in allergen immunotherapy.

Short Ragweed Pollen Allergenic Extract and Short and Giant Ragweed Pollen Mix Allergenic Extract: Short Ragweed Pollen Allergenic Extract and Short and Giant Ragweed Pollen Mix Allergenic Extract are indicated for skin test diagnosis of patients with a clinical history of allergy to ragweed pollen (Short Ragweed or Short and Giant Ragweed pollen), and immunotherapy for the reduction of ragweed pollen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for pollen-specific IgE antibodies for Short and/or Giant Ragweed pollen.

Standardized Cat Hair Allergenic Extract: Standardized Cat Hair Allergenic Extract is indicated for skin test diagnosis of patients with a history of allergy to cats and treatment of cat hair-induced allergic asthma, rhinitis and conjunctivitis when avoidance is not possible.

Standardized Grass Pollen Allergenic Extracts: Standardized Grass Pollen Allergenic Extracts are indicated for skin test diagnosis of patients with a clinical history of allergy to one or more of the following grass pollens: Bermuda, Kentucky Blue (June), Meadow Fescue, Orchard, Perennial Rye, Redtop, Sweet Vernal, Timothy; and immunotherapy for the reduction of grass pollen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for pollen-specific IgE antibodies for Bermuda, Kentucky Blue (June), Meadow Fescue, Orchard, Perennial Rye, Redtop, Sweet Vernal, or Timothy grass pollens.

Standardized Mite Extracts: Standardized Mite Allergenic Extracts are indicated for diagnosis of skin test reactivity to dust mite allergen and treatment of mite-induced allergic asthma, rhinitis and conjunctivitis in patients that show hypersensitivity to dust mites based on clinical history, allergen exposure history, and skin test reactivity.

Please click here for Package Inserts with full Prescribing Information, including Boxed Warnings.

To report suspected adverse reactions, contact Stallergenes Greer at 1-855-274-1322 or FDA at 1-800-FDA-1088 or www.fda.gov/Safety/MedWatch.